‘Ketamine Queen’ Faces Sentencing in Matthew Perry Death
The final phase of the criminal case surrounding the death of Matthew Perry is unfolding in a Los Angeles federal courtroom, where convicted drug dealer Jasveen Sangha is set to be sentenced for supplying the ketamine that led to the actor’s fatal overdose. Prosecutors have labeled Sangha the “Ketamine Queen,” arguing she ran a lucrative and dangerous drug operation that catered to high-paying clients while ignoring the risks. “She chose profits over people.” That is the central argument from federal prosecutors seeking a 15-year prison sentence. They contend Sangha operated a steady pipeline of illegal ketamine distribution, continuing to sell the drug even after prior overdoses were linked to her network.
What Happened to Matthew Perry
Matthew Perry, widely recognized for his role as Chandler Bing, died in October 2023 at age 54. The official cause of death was determined to be the acute effects of ketamine, a powerful anesthetic that has legitimate medical uses but has increasingly become a substance of abuse. In the months leading up to his death, Perry had reportedly been undergoing supervised ketamine therapy as part of treatment for depression. However, investigators say he began seeking higher doses than doctors were willing to prescribe. That shift pushed him into an underground supply chain involving intermediaries, medical professionals operating outside ethical boundaries, and dealers like Sangha. Authorities say Sangha ultimately supplied a large quantity of ketamine through a middleman connected to Perry. In the final days before his death, multiple doses were administered, including injections on the day he was found unresponsive in a hot tub at his Los Angeles home.
The Criminal Network Behind the Overdose
The case extends far beyond a single dealer. Five individuals in total have pleaded guilty in connection with Perry’s death, including two doctors, a drug intermediary, and Perry’s personal assistant. But prosecutors have drawn a sharp distinction with Sangha. She is the only defendant who admitted that her distribution directly resulted in Perry’s death, placing her at the center of the case and exposing her to the most severe sentencing risk. The investigation revealed a network where medical legitimacy and illicit drug distribution blurred together, creating an environment where access to controlled substances became dangerously easy for someone already struggling with addiction.
The Charges and Guilty Plea
Sangha pleaded guilty to five federal charges tied to her drug operation. These include maintaining a property used for drug distribution, multiple counts of ketamine distribution, and distribution resulting in death. Prosecutors describe her operation as extensive and profit-driven, alleging she knowingly supplied dangerous quantities of ketamine without regard for safety or consequence.
Defense Pushes Back
Sangha’s defense team is seeking a significantly reduced sentence, arguing for leniency based on her lack of prior criminal history and her conduct since arrest. Her attorneys describe her actions as a deviation rather than a pattern, emphasizing her participation in rehabilitation programs while in custody. They argue that a lengthy prison sentence is unnecessary and that she is capable of reintegration into society.
A Family Still Demanding Accountability
For Perry’s family, the sentencing represents a moment of reckoning. They have made clear through court filings that the loss is irreversible and that those responsible should face meaningful consequences. The emotional weight of the case has underscored the broader human cost behind the legal proceedings, turning what could have been another overdose statistic into a high-profile demand for accountability.
Why This Case Matters
This case stands out because it targets not just individual drug use, but the system that enabled it. Federal prosecutors have pursued an aggressive strategy, holding multiple actors accountable across the supply chain, including licensed professionals. It also highlights the growing tension around ketamine’s dual identity. While it is increasingly used in controlled medical settings to treat mental health conditions, its availability outside those boundaries has created new risks. The death of Matthew Perry has become a stark example of how quickly that line can be crossed.
What Comes Next
A federal judge will determine Sangha’s sentence, weighing arguments from both sides about culpability, deterrence, and rehabilitation. The outcome could influence how similar overdose-related cases are prosecuted in the future. For now, the case closes a major chapter in the aftermath of Matthew Perry’s death, while raising lasting questions about addiction, accountability, and the systems that failed him.
